COMPASS Pathways granted two US patents
March 23, 2021 08:00 ET
|
COMPASS Pathfinder Ltd.
COMPASS Pathways granted two US patents London, UK – 23 March 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access...
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
February 09, 2021 07:02 ET
|
Compass Pathways
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic...
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
February 03, 2021 07:00 ET
|
Compass Pathways
Formal and scalable methodology for psychological support in psilocybin therapyLondon, UK – 3 February 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
November 09, 2020 07:00 ET
|
Compass Pathways
London, UK - 9 November 2020 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has...
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares
September 22, 2020 16:03 ET
|
Compass Pathways
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares London, UK –...
COMPASS Pathways announces pricing of upsized initial public offering
September 17, 2020 22:40 ET
|
Compass Pathways
COMPASS Pathways announces pricing of upsized initial public offering London, UK – September 18, 2020 COMPASS Pathways plc (Nasdaq: CMPS)...